Is Strut Health legit and worth it?
Strut Health is a real GLP-1 telehealth provider; we read its site and scored it 3.0/5 in our independent review (Use Caution). It is best for self-directed patients who want straightforward access to affordable compounded GLP-1 medications and do not require ongoing clinical support or extensive hand-holding. Biggest plus: Pricing: $99 - $199. Watch-out: No/minimal Trustpilot reviews.
Scorecard: strongest in Access (4.7/5) and Cost & Value (4.6/5); weakest in Reputation (2.0/5) and Support (2.0/5).
Medications
Semaglutide, Tirzepatide (as entered 10 April 2026; capture date not recorded); Compounded oral semaglutide, oral tirzepatide (oral, seen on its site 14 October 2026)
Monthly Cost
$99 – $199 (as entered 10 April 2026; capture date not recorded)
Speed to Start
Fast
Trustpilot
Not yet rated (as recorded April 2026; not re-checked)
Prices and medications in this review are as entered in our research on 10 April 2026 (the date we captured them was not recorded), unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2020
About Strut Health
Strut Health has been in operation since 2020, giving it more tenure than many of its GLP-1 telehealth competitors. The platform offers compounded semaglutide and compounded tirzepatide at prices ranging from $99 to $199 per month — a straightforward and relatively affordable pricing structure. However, despite several years in the market, Strut Health has struggled to build the external validation and clinical depth that our editorial team looks for in a recommended provider.
The most notable gap in Strut Health’s profile is its complete absence from Trustpilot. With zero Trustpilot reviews, prospective patients have no independent peer feedback to reference when evaluating this provider. For a company that has been operating for over five years, this is an unusual and concerning gap. Most providers of this tenure have accumulated at least some review history, and the complete absence suggests either very low patient volume or a lack of engagement with review platforms that patients commonly rely on.
A B+ grade indicates that the company has generally responded to complaints and maintained acceptable business practices, even if there are some unresolved issues.
The clinical offering at Strut Health is limited. The platform does not include lab testing or dietitian access, and our research indicates low ongoing support — meaning patients should not expect frequent check-ins, proactive outreach, or robust customer service after their initial consultation. For patients who are self-directed and simply want access to affordable compounded GLP-1 medications without extras, this stripped-down model may be adequate. For anyone expecting a guided experience, it will likely feel insufficient.
At its core, Strut Health is a basic, no-frills compounded medication provider with reasonable pricing and minimal support infrastructure. The total absence of patient reviews after five years in business is a data point that cannot be ignored. Our editorial team sees this as a provider that functions adequately for its narrow purpose but has not demonstrated the clinical quality, patient engagement, or reputation building necessary to earn a strong recommendation.
Strut Health GLP-1 Medications
Screenshot of Strut Health, captured by 10 April 2026
Screenshot of Strut Health, captured by 10 April 2026
Screenshot of Strut Health, captured by 10 April 2026
Screenshot of Strut Health, captured by 10 April 2026
Screenshot of Strut Health, captured by 10 April 2026
At a Glance
Medications Offered
Semaglutide, Tirzepatide (as entered 10 April 2026; capture date not recorded); Compounded oral semaglutide, oral tirzepatide (oral, seen on its site 14 October 2026)
Compounded
Cost & Insurance
- Monthly: $99 – $199 (as entered 10 April 2026; capture date not recorded)
- 6-month estimate: $599 – $1199 (as entered 10 April 2026; capture date not recorded)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Pharmacies named: Partner compounding pharmacies (Dallas, TX based); specific names not publicly disclosed
Delivery & Access
- Format: Both (Oral and Subcutaneous)
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
What the Strut Health Intake Looks Like
We walked through Strut’s full GLP-1 intake ourselves, from the signup gate to the biometric ID verification. Here’s what an actual prospective patient encounters before being prescribed.
/ 10
Solid for a compounded-only provider — dedicated MTC family-history, pancreatitis with explicit “elevated lipase” specificity, two gallbladder questions, and a brand-name GLP-1 allergy screen. Knocked down by the absence of a validated PHQ, eating-disorder, or substance/alcohol screen and by a single 3-point combined diet/activity question.
/ 10
Above average. Account creation comes first (email and phone or Google SSO before any clinical question), and Strut requires Persona biometric ID verification — government photo ID plus a face match — before checkout. Only the second observed provider in our catalog to require this level of identity verification.
The 10 Stages
Clinical Safety Screens Performed
Strut’s intake doesn’t use a validated PHQ-2 or PHQ-9 depression screen — suicidal ideation history is a checkbox in the GI/safety multi-select rather than its own question. There is no dedicated eating-disorder screen, no substance or alcohol screen, no general drug or food allergy screen beyond the GLP-1 class, no actual blood pressure reading, and no diet or exercise history depth (one combined 3-point lifestyle question). Sex at birth is collected as a binary Male/Female only, with no separate gender identity question. MEN2 is not named explicitly — the FDA black-box screen covers MTC personal and family history but uses “thyroid nodules” as its accompanying wording.
Strut’s questionnaire includes an unusual 8-option multi-select asking why a patient needs compounded Semaglutide rather than commercial brand-name GLP-1: an allergy to a commercial-product ingredient, microdosing or non-standard titration needs, B6 (pyridoxine)-modified side-effect mitigation, B6 supplementation for energy/fatigue/neuropathy, GLP-1 not being available in commercial form, inability to use injections (with the oral lozenge as an alternative), or “other reason.” The form notes explicitly that “cost is not an acceptable reason” on the other-reason free-text field. This framing reflects the post-shortage compounding landscape, where a patient-specific medical justification is required to dispense a compounded version of a commercially available product.
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the Strut Health weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens struthealth.com in a new tab.
Start your GLP-1 weight loss journey with Strut Health today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
